Steven Cohen Candel Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$3.05 - $4.08 $1.04 Million - $1.39 Million	-339,951 Reduced 45.75%	403,131 $1.27 Million
Q2 2022 Aug 15, 2022	BUY	$3.13 - $5.56 $2.33 Million - $4.13 Million	743,082 New	743,082 $2.41 Million

6.41M

109K

130K

Ticker CADL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,891,900
Market Cap $256M
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.